Over 12% rise in one day and possibly just the start of much bigger things to come, with the trial coming to an end, which I see as mostly a formality given the product had already shown great results. I reckon it’s coming time for patients to get the help they need and for shareholders to get a great return well above current prices. DYOR.
run coming?, page-40
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
